More Post from the Author
- Liftoff Announces Confidential Submission of Draft Registration Statement for Proposed Initial Public Offering
- /C O R R E C T I O N -- Educate 360/
- Dan Williams Promoted to Century Fasteners Corp. - General Manager, Operations
- DORSIA DEBUTEERT DE CULTURE CALENDAR TIJDENS ART WEEK IN MEXICO-STAD BIJ SOL A SOL
- TestMu AI (anteriormente LambdaTest) presenta los ganadores del 2025 Partner of the Year Award
Indivior Statement RE: Delayed FDA Approval of SUBLOCADE Label Changes
Published on Wed 12 Feb 2025 8:07:04 UTC
RICHMOND, Va., Feb. 12, 2025 /PRNewswire/ --Indivior PLC (Nasdaq/LSE: INDV)provides the following update regarding its PDUFA action date for label changes (rapid initiation protocol and alternative injection sites) for SUBLOCADE (buprenorphine extended-release) Injection, which was scheduled for February 7, 2025:
Yesterday, February 11th, the FDA informed Indivior that, following acceptance of the proposed label for SUBLOCADE, there were no outstanding items to address, but that final review of the SUBLOCADE label changes has been delayed.
Indivior will provide further updates on the status of the approval of the proposed SUBLOCADE label changes as appropriate.
SOURCE Indivior PLC
More Post from the Author
- Liftoff Announces Confidential Submission of Draft Registration Statement for Proposed Initial Public Offering
- /C O R R E C T I O N -- Educate 360/
- Dan Williams Promoted to Century Fasteners Corp. - General Manager, Operations
- DORSIA DEBUTEERT DE CULTURE CALENDAR TIJDENS ART WEEK IN MEXICO-STAD BIJ SOL A SOL
- TestMu AI (anteriormente LambdaTest) presenta los ganadores del 2025 Partner of the Year Award